The Spectrum of Infections in Patients with Lung Cancer


ULUSAN BAĞCI Ö., UNAT Ö. S., KÖSE Ş., CANER A., SERCE UNAT D.

CANCER INVESTIGATION, vol.1, no.41, pp.25-42, 2023 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Volume: 1 Issue: 41
  • Publication Date: 2023
  • Doi Number: 10.1080/07357907.2022.2153860
  • Journal Name: CANCER INVESTIGATION
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.25-42
  • Dokuz Eylül University Affiliated: Yes

Abstract

Although diagnostic and therapeutic advances in Lung cancer (LC) have increased the survival of patients, infection and its complications are still among the most important causes of mortality. The disruption of tissue caused by tumor mass, management of cancer therapy and alteration in the humoral/cellular immune systems due to both cancer itself and therapy considerably increase susceptibility to infection in cancer patients. Particularly, opportunistic microorganisms should be considered, then applying rapid and sensitive diagnostic methods for them. Thus, cancer patients who are already exposed to difficult, long-term and expensive treatments can be prevented from dying from complications related to infections.